BUSINESS3 years ago
Amyris Inc. (NASDAQ: AMRS) And ImmunityBio (NASDAQ: IBRX) Close Joint Ventures Agreement To Accelerate Next-Gen COVID-19 Vaccine Development
Amyris Inc. (NASDAQ: AMRS) and ImmunityBio (NASDAQ: IBRX) have announced the closing of a previously announced JV agreement to expedite the commercialization of a flagship next-gen...